Quick Search 
Drugs of the Future
Register or sign in

Volume 39, Issue 8, August 2014, Pages 541-601
Protein kinase B (PKB) inhibitor, Oncolytic.
Conkel, M., Benson, D.M. Jr.
Drugs Fut 2014, 39(8): 541
Summary | Full Text: PDF 
Tyrosine-protein kinase JAK1 inhibitor, Treatment of rheumatoid arthritis, Treatment of Crohn's disease.
Gras, J.
Drugs Fut 2014, 39(8): 547
Summary | Full Text: PDF 
Humanized anti-sclerostin monoclonal antibody, Treatment of osteoporosis.
Paton, D.M.
Drugs Fut 2014, 39(8): 553
Summary | Full Text: PDF 
 Emerging animal models in scientific research.
Vila, R., Castaner, R., Cole, P.
Drugs Fut 2014, 39(8): 557
Summary | Full Text: PDF 
 O-GlcNAc's role in neurological disorders and its therapeutic implications.
Patel, D.M., Whisenhunt, T.R., Markert, J.M.
Drugs Fut 2014, 39(8): 561
Summary | Full Text: PDF 
 Therapeutic targets for hemophilia.
Sorbera, L.A., Navarro, D.P., Rosa, E.
Drugs Fut 2014, 39(8): 569
Summary | Full Text: PDF 
 Pipeline on the move.
Navarro, D., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2014, 39(8): 577
Full Text: PDF 
 33rd Meeting of the European Academy of Allergy and Clinical Immunology (EAACI), Copenhagen, Denmark – June 7-11, 2014.
Croasdell, G.
Drugs Fut 2014, 39(8): 585
Summary | Full Text: PDF 
 Society of Nuclear Medicine and Molecular Imaging (SNMMI), St. Louis, Missouri, USA – June 7-11, 2014.
Rabasseda, X.
Drugs Fut 2014, 39(8): 589
Summary | Full Text: PDF 
 The European League Against Rheumatism (EULAR), Paris, France – June 11-14, 2014.
Sherwood, D.
Drugs Fut 2014, 39(8): 597
Summary | Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy